30
220 © 2014 Elsevier Ltd 8 Microfluidic devices for rapid identification and characterization of pathogens H. BECKER, T. HANSEN-HAGGE and C. GÄRTNER, microuidic ChipShop GmbH, Germany DOI: 10.1533/9780857099167.2.220 Abstract: The scientic progress in microuidics and the technical development of microuidic-enabled devices for diagnostic applications have led to a signicant growth in industrial interest in bringing such systems into the diagnostic market. In this review, we discuss the underlying technological challenges present in the development of microuidic devices that integrate all steps of a molecular diagnostics workow, for example. We present a variety of examples of how different types of pathogen analyses are carried out using microuidic chips. Different chip-based methods such as polymerase chain reaction (PCR) or immunoassays are discussed in detail. An overview on existing commercial solutions complements these examples. Key words: microuidics, cartridge, chip, molecular diagnostics, immunoassay, polymerase chain reaction (PCR). 8.1 Introduction Similarly to the microelectronic revolution 50 years ago, a comparable development can be seen with the introduction of miniaturization in the life sciences with the initial concept of the so-called ‘miniaturized total analysis system’ ( μ-TAS), also often called ‘Lab-on-a-Chip’ (LoC) technology, which deals with the handling and manipulation of miniature amounts of liquid in analyses conducted within life sciences research and was introduced about 20 years ago (Manz et al., 1990; Vilkner et al., 2004; Lee and Lee, 2004; Haeberle and Zengerle, 2007; Becker, 2008). Recent years have witnessed an explosive growth of scientic activities in the Lab-on-a-Chip technology. While the number of scientic publications within the ‘microuidics’ area has dramatically increased in the timeframe of 2000 to 2010, the progress in commercializing microuidics- enabled products has been much slower than anticipated (Blow, 2009; Becker, 2009a), reecting a ‘looking for a problem methodology’ rather than a widely used truly enabling technology. In the last few years, however, this situation has changed, as a critical mass of knowledge seems to have been achieved, which led to a signicant increase in commercial activities making use of LoC technologies. Nowadays almost no product development in the eld of diagnostics (especially

Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

  • Upload
    h

  • View
    213

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

220

© 2014 Elsevier Ltd

8 Microfl uidic devices for rapid identifi cation

and characterization of pathogens

H. BECKER, T. HANSEN-HAGGE and C. GÄRTNER, microfl uidic ChipShop GmbH, Germany

DOI: 10.1533/9780857099167.2.220

Abstract: The scientifi c progress in microfl uidics and the technical development of microfl uidic- enabled devices for diagnostic applications have led to a signifi cant growth in industrial interest in bringing such systems into the diagnostic market. In this review, we discuss the underlying technological challenges present in the development of microfl uidic devices that integrate all steps of a molecular diagnostics workfl ow, for example. We present a variety of examples of how different types of pathogen analyses are carried out using microfl uidic chips. Different chip- based methods such as polymerase chain reaction (PCR) or immunoassays are discussed in detail. An overview on existing commercial solutions complements these examples.

Key words: microfl uidics, cartridge, chip, molecular diagnostics, immunoassay, polymerase chain reaction (PCR).

8.1 Introduction

Similarly to the microelectronic revolution 50 years ago, a comparable development can be seen with the introduction of miniaturization in the life sciences with the initial concept of the so- called ‘miniaturized total analysis system’ ( μ -TAS), also often called ‘Lab- on-a-Chip’ (LoC) technology, which deals with the handling and manipulation of miniature amounts of liquid in analyses conducted within life sciences research and was introduced about 20 years ago (Manz et al. , 1990; Vilkner et al. , 2004; Lee and Lee, 2004; Haeberle and Zengerle, 2007; Becker, 2008). Recent years have witnessed an explosive growth of scientifi c activities in the Lab- on-a-Chip technology. While the number of scientifi c publications within the ‘microfl uidics’ area has dramatically increased in the timeframe of 2000 to 2010, the progress in commercializing microfl uidics- enabled products has been much slower than anticipated (Blow, 2009; Becker, 2009a), refl ecting a ‘looking for a problem methodology’ rather than a widely used truly enabling technology. In the last few years, however, this situation has changed, as a critical mass of knowledge seems to have been achieved, which led to a signifi cant increase in commercial activities making use of LoC technologies. Nowadays almost no product development in the fi eld of diagnostics (especially

Page 2: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 221

molecular diagnostics) or the analytical sciences takes place that does not in one form or another involve elements with microfl uidic functionality. Furthermore, the value of this technology has fi nally also been realized in the markets, as can be seen from the large number of acquisitions in the fi eld. The technological as well as commercial challenges for microfl uidic technology will be described in this paper using the example of microfl uidic devices designed for rapid identifi cation and characterization of pathogens.

8.2 Challenges and technical as well as commercial

solutions

There is unquestionably a need for smart, robust, reliable as well as rapidly functioning, and portable devices able to detect an infection of harmful pathogens or a biological threat (Weile and Knabbe, 2009).

First very simple ‘dipsticks’ have been sold as ‘lateral- fl ow tests’ since the late 1980s (Mark et al. , 2010). Examples that are still on the market today are test strips for pregnancy (Chard, 1992), drug abuse (Litman et al. , 1983; Pacifi ci et al. , 2001), cardiac markers (Siebenhaar et al. , 2010) and also upcoming bio- warfare protection (Shyu et al. , 2002). Apart from these very basic analysis systems, the number of appropriate microfl uidic devices on the diagnostic market has only been slowly increasing. One explanation of this phenomenon is the presence of a signifi cant number of still underestimated challenges and obstacles, which have to be overcome during device development (Becker et al. , 2008; Mark et al. , 2010 and 2012). A (semi-)quantitative analysis is always accompanied by a set of control or reference analyses performed in parallel, which accordingly increases the number of microfl uidic channels, valves (Oh and Ahn, 2006), mixers (Nguyen and Wu, 2005) and control or monitoring elements. All these elements have to fi nd their place on a cartridge with limited footprint and have to cooperate in a smooth manner.

Complexity as well as distinctive features of the analytical process (e.g. discrimination of different HPV sub- types (Anic and Giuliano, 2011; see below) via multiplex analysis or investigation of pathogens in grain, which is quite resistant to lysis, etc.) will strongly affect the choice of chip material (e.g. polymers with high glass transition temperature and low autofl uorescence; material that is inert to organic solvents; structured glass, etc.), geometry (e.g. microtiter plate or microscopy- slide-sized chips, compact disc type cartridge, laminated cartridge layers, etc.), dimensions and fabrication mode of the cartridge (e.g. hot embossed, injection molding, etching, etc.). For disposable devices, which are required for any diagnostic test, polymers turn out to be the material of choice in most cases due to material cost and fabrication options.

Page 3: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

222 Biological Identifi cation

An early but periodically repeated estimation of fabrication costs (COG, costs of goods) during the course of diagnostic device development is essential in order to achieve the acceptance of the future product by the market (Becker, 2009b). Here, it has to be kept in mind that the cartridge is not composed only of structured plastic but, rather, a composition of quite different materials and elements (e.g. membranes for fi ltration, magnetic beads for nucleic acid purifi cation, gold arrays for electrochemical detection, etc.). Against this background, it is also very important to keep in mind that the assembly of different elements to a functional unit (back- end processing) will considerably affect the costs of production for the fi nal integrated device. In analogy to fabrication experiences in the microelectronic world, these so- called back- end processes can account for up to 80% of the overall manufacturing cost, and therefore have to be thoroughly investigated during product development.

After selection of cartridge material and mode of fabrication, it is recommended to defi ne, produce and validate separately each individual function of the bioanalytical process protocol, such as sample processing, cell lysis, fi ltration, analyte purifi cation, target sequence amplifi cation, and detection by the use of dedicated microfl uidic modules. Positively evaluated units can subsequently be compiled into an integrated platform. This process ideally culminates in a fully integrated sample- in answer- out cartridge.

A typical bioanalytical process encompassing sample collection and processing, analyte amplifi cation, analyte purifi cation, detection and the overall solution management is schematically illustrated in Fig. 8.1. The type of sample can be very different (e.g. biopsy, swab, sputum, blood, etc.) and, accordingly, the ‘world- to-chip’ interface (Schulte et al. , 2000) has to be adapted to the respective type of sample. Although these interfaces are still an often overlooked but important item during product development, more and more existing standards

8.1 Schematic diagram of the typical process steps involved in a bioanalytical or diagnostic process fl ow in a microfl uidic device.

Page 4: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 223

from the targeted application area (e.g. Luer-Lock compatible interfaces in clinical diagnostics) are used, however, with disadvantages mainly in terms of size. For this reason, a similar press- fi t interface with a reduced footprint (called ‘mini-Luer’) has been developed, allowing up to 32 fl uidic ports on a device the size of a microscopy slide.

The next step – the various sample preparation processes, such as disintegration and/or dissolving of the sample, cell lysis, extraction of DNA/RNA, sample concentration, etc. – have so far typically been carried out off- chip due to their complexity and the different nature of the various samples. Moving these steps onto the device represents the biggest challenge (Kim et al. , 2009), because several media (wash buffer, carrier buffer, beads, lysing agents, etc.) usually have to be handled sequentially, robustly and with a high precision in terms of volume, times or sequence. All processes require interfaces and plumbing in very restricted device areas.

As discussed later in more detail, the next process step usually is the amplifi cation of the analyte if nucleic acids are used as analytical targets. This amplifi cation step is then frequently followed by a process step for the separation of the analyte of interest. For this separation, various techniques exist, such as electrophoresis, chromatography (up to now not well developed on- chip) and the use of capture probes (e.g. DNA arrays) or other fi ltration mechanisms in order to isolate the desired component spatiotemporally or to remove unwanted components from the mixture.

The fi nal analytical step comprises the detection of the analyte of interest. For many larger, lab- based systems, optical detection methods (Kuswandi et al. , 2007) like laser- induced fl uorescence still act as a benchmark with respect to sensitivity. For portable systems, electrochemical analysis methods or various other sensor methods (e.g. electrochemical sensors, surface acoustic waves (SAW), quartz crystal microbalance (QCM), thermal measurements) are becoming increasingly of interest. It should be noted that all the preceding process steps have to be matched to the selected detection method in order to generate the best results.

A minor but nevertheless important design step of an integrated device in diagnostics is the layout of a waste container system in order to retain all liquids used in the process on- chip. This is often necessary in order to avoid the risk of contaminating the instrument and to prevent carry- over from one measurement to the next. The required volume of such waste reservoirs can be critical, frequently stressing the limited real estate on the chip.

As mentioned above, the type of analyte, pathogen and sample source affect the strategy of resulting approaches for the development of microfl uidic analytical devices. Normally, analytic targets are either nucleic acids (McCalla et al. , 2011) or pathogen- indicating proteins (Kuswandi, 2007; Lee and Lee 2004; Lee et al. , 2009, 2010). In some cases, such as HIV diagnostics, intact cells are the targets for an immunological analysis (Chin et al. , 2011). Pathogens (Gordon et al. , 2011;

Page 5: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

224 Biological Identifi cation

Loubiere and Moatti, 2010; Franz, et al. , 1997) can belong to quite diverse classes of different biological kingdoms, such as eukaryotes (helminths, fungi, etc.), prokaryotes, and – very important – viruses. The latter encompass a very central class of pathogenic agents. As a fi rst overview, a non- exhaustive list of commercial (available) devices is given in Chin et al. (2012).

8.3 Pathogens and analytes

One important advantage of the LoC technology (here we expand the notation from ‘lab on a chip’ also to lab on a cartridge/compact disc/cassette) (Janasek et al. , 2006; Manz et al. , 1990) is its POC (point of care, but here also used in the context of point of occurrence) applicability (Lewandrowski, 2009). To illustrate this, different scenarios are described in the following.

Robust, reliable, and cheap POC testing of HIV (Briggs et al. , 2012) – especially, but not exclusively, in developing countries – is one very urgent need. This includes both fi rst diagnosis of the disease as well as monitoring of the course of the disease under therapy. A second family of viruses, which should be controlled at the POC, is represented by the infl uenza virus (Mak et al. , 2012). Here, LoC-based bioanalytical testing facilitates a comprehensive monitoring of the spreading of the infection from a local outbreak to an epidemic or even pandemic dissemination. In addition, LoC devices will allow a rapid discrimination between harmful and ‘harmless’ virus strains. And a rapid LoC-based infl uenza diagnosis in the doctor’s offi ce by a general practitioner will allow an immediate therapeutic response to the infection and may help to prevent spreading of the infl uenza inside the doctor’s waiting room. As a third example, human papilloma viruses (HPV) have been intensively studied, and it has been found that certain HPV strains cause cervical cancer and others do not. Fortunately, an early therapy can erase the viral infection and the concomitant risk of cancer. Against this background, it is anticipated that POC diagnostics will permit rapid screening for those HPV subtypes causing cancer (Saxena et al. , 2012). This will defi nitely increase the frequency of identifi ed risky HPV infections, will decrease the time span between diagnosis and therapy, and, thereby, will help to save lives.

The battle against bacterial infections is still not won – despite antibiotics. This is due to the capability of bacterial pathogens to develop multiple resistances against antibiotic drugs in a surprisingly short period of time. Accordingly, increasing interest can be noted in the development of improved therapeutic as well as diagnostic tools (Mothershed and Whitney, 2006) for bacteria such as methicillin- resistant Staphylococcus aureus (MRSA; in fact, the name of this S. aureus strain could also be multi- resistant Staphylococcus aureus ) (Lu et al. , 2013). It is expected that a rapid and locally focused monitoring of MRSA – and other multi- resistant bacteria – will support containment of further outbreaks of the respective types of pathogens (Focke et al. , 2010). Mycobacterium

Page 6: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 225

tuberculosis (Niemz et al. , 2012) is also a pathogen able to gain multiple resistances against drugs. On top of multi- resistant Mycobacterium tuberculosis , totally drug- resistant TB was identifi ed in 2002 in Italy. Other activities focus on the development of POC tests for lower respiratory tract infections such as community or respiratory- acquired pneumonia or tuberculosis (see, e.g., the European project RAPP-ID, http://www.imi.europa.eu/content/rapp- id ). In summary, an adequate response to the ‘rearmament’ of pathogenic bacteria is urgently required and POC diagnostics will be one important weapon to win this ‘war against antibiotics resistance’. On top of this, bacteria are also misused as weapons by humans. This creates a strong need for POC diagnostics in the framework of CBRN (chemical, biological, radiological and nuclear) defense scenarios as well.

The amplifi cation of target DNA sequences via PCR (Mullis et al. , 1986; Saiki et al. , 1988) is a very effi cient and well- established technique for the detection of the respective target in the investigated sample. Accordingly, this methodology is well established in food, clinical, forensic and veterinary analysis and – to a slightly lesser extent – POC diagnostics (Zhang and Xing, 2007; Park et al. , 2011). Unfortunately, the detection of pathogen- indicating DNA does not necessarily indicate the presence of an ongoing infection with the respective living and virulent pathogen. Due to the enormous sensitivity of this amplifi cation technique, residual debris of destroyed pathogens within the sample could also give rise to a false (regarding biological threat) positive signal. One possible way out of the above dilemma is the examination of RNA instead of DNA (Mocharla et al. , 1990). The RNA pool represents a collection of all expressed genes of a living organism. Thus, the turnover of the pool happens very rapidly. As a consequence, this phenomenon keeps the monitoring of expressed genes and, therewith, of the infection status up- to-date. As stated above, and as will be described in detail below, the development of a miniaturized PCR platform will have to address a large number of challenges before such a complex technology will be successfully implemented in a small device.

The conversion of the immunological ELISA (enzyme- linked immunosorbent assay) approach (Henares et al. , 2008; Dutse and Yusof, 2011; Engvall and Perlmann, 1971) into a LOC device (Rossier and Girault, 2001) is less complicated than the PCR approach. As a consequence, this technique is realized in quite different lateral fl ow devices (Glad and Grubb, 1978; Martinez, 2011; Clerc and Greub, 2010). Moreover, the method is sensitive enough to offer an unequivocal diagnosis of pathogens in many cases (von Lode, 2005) and the antibody/antigen interaction can specifi cally monitor and quantify molecules such as drugs and metabolites (Ibrahim et al. , 2009), large proteins (Minkstimiene et al. , 2009), nucleic acids (Blazkova et al. , 2009) and even whole pathogens (Rica et al. , 2009). The quality of each individual analysis depends on a large variety of different parameters (density of the trapping antibody, temperature,

Page 7: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

226 Biological Identifi cation

pH, storage time of chip and ingredients until analysis, etc.). Accordingly, control experiments with internal standards are recommended in those cases where a simple ‘yes’ or ‘no’ is not suffi cient. Such a sophisticated approach cannot be achieved by most lateral fl ow devices. In addition, the implementation of internal standards or multi- parameter analysis (Lee et al. , 2009) is also desired because this allows semi- quantitative information to be obtained with respect to the number of infectious organisms in the investigated sample.

8.4 Chip- based analysis of protein- based analytes in

microfl uidic devices

The term ELISA describes a technique in which biomolecules are immobilized on an activated solid phase in an initial step (Fig. 8.2(a)). In order to become activated, the surface of chip- based cavities or channels must be, for instance, exposed to oxidizing plasma and subsequently incubated with an appropriate chemical surface modifi er, which carries reactive chemical groups, such as the epoxy group. These chemical groups fi nally allow the immobilization of the trapping molecule (e.g. antigen; Fig. 8.2(b)) to the surface. This can be an antigen, an antibody or any other biomolecule that can be involved in an immunological binding reaction. The next step is the visualization of the immobilized complex of trapping and target molecule, as depicted in Fig. 8.2(b). In this example, a secondary antibody binds to an antigen as target and visualizes the complex with the help of a fl uorescent dye.

As described earlier, the very basic design of lateral fl ow devices does not allow quantitative information to be generated at a high sensitivity level. In fact, lateral fl ow devices only allow a qualitative result of reduced sensitivity. Although suffi cient in many cases, the potential of this still commercially very successful technique has reached its limit. Accordingly, cartridge- based ELISA tests have been developed in order to improve the reliability, sensitivity and robustness of analyses at a POC environment.

Similarly to the sample repertoire of lateral fl ow devices, the majority of cartridge- based ELISA tests are designed as blood analysis tools, where either blood plasma or serum is separated from blood cells by on- cartridge fi ltration or whole blood is directly analyzed, as is realized in the case of a device developed by the company Daktari Diagnostics. Alternatively, the blood sample is lysed on- chip and transported in processed form over the sensor area (Table 8.1) (listed as a Claros Diagnostics technique, now a subsidiary of Opko Diagnostics) (Fig. 8.3 and 8.4). This approach is exemplifi ed by a device from Opko Diagnostics ( http://www.opko.com/products/point- of-care- diagnostics/ ) with a workfl ow shown in Fig. 8.3. As shown in Fig. 8.3(a), the cassette is composed of two independent fl uidic systems, each being essentially a long channel with variable geometry. The system shown on the left is used for the storage of multiple liquid reagents in

Page 8: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 227

8.2 Schematic drawings of the functionalization process in order to immobilize the trapping biomolecule (a) and the basic steps of analyte immobilization and visualization (b).

the form of plugs of liquid separated by gas segments. The geometry of the channels is optimized for stability of the air–gas interface upon storage. The system shown on the right is designed to perform the assay: from the inlet (bottom) the channel defi nes multiple detection zones, and then turns into a waste collection chamber. Each of the detection zones can be coated with a different capture probe, to perform multiplex assays. The illustration shows three zones, although actual designs have up to ten detection zones. At the time of manufacture, the cassette is loaded with appropriate reagents (in storage channels, and detection zones). All ports of the fl uidic systems are sealed for transportation and storage. To operate the test, the user collects the specimen of whole blood in a sample collection device. The volume of 12 μ l of

Page 9: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

228 Biological Identifi cation

blood necessary to run the assay can be obtained from a fi nger stick. The user connects the collection device to the cassette (Fig. 8.3(b)), effectively connecting the two fl uidic systems into one long fl uidic structure. The cartridge is inserted in the analyzer, which applies a source of vacuum at the outlet of the system (at the port located downstream of the waste chamber). The pressure gradient sustains fl ow of sample into the detection zones, and also starts moving the reagent plugs towards the waste collection chamber (Fig. 8.3(d)). The fl uidic system is essentially a single conduct (Fig. 8.3(d)), and all fl uids fl ow towards the vacuum source, sequentially traveling through the detection zones. The last fl uid to fl ow through the detection zone is an amplifi cation reagent, which creates an optically detectable signal.

Capillary forces are the main moving power for lateral fl ow devices. In products more sophisticated than application of the lateral fl ow approach, fl uid actuation is required, which can be realized in quite different ways. In the commercial devices listed in Table 8.1, for instance, capillary, pneumatic, centrifugal and, last but not least, gravitational forces have been applied. Pneumatic and centrifugal forces can be applied with the help of a syringe and a CD player- like device, respectively.

The implementation of sensors is as diverse as the mode of actuation. Detection can be by electrochemical (e.g. electrochemical impedance), fl uorescent or colorimetric monitoring, or by adsorption. In order to improve the signal- to-noise ratio additionally, washing and dilution steps are included in the bioanalytical process of some of the devices. For this, the required liquids have to be provided, either from outside during the analysis or from reservoirs stored on board.

Many of the above products are still under development, and there are ongoing attempts to expand the portfolio of a system to additional analytes and, moreover, to simplify the technique in order to increase the acceptance of the user at the POC. Along these lines, mainly viruses, such as HIV, infl uenza or HPV, and bacteria, such as MRSA or Shigella toxin- expressing E. coli , are in the focus of portfolio expansion.

As a brief intermediate summary, the mode of actuation as well as control of fl ow direction (via valves, for instance) should be realized as simply as possible, in order to keep the confi guration of the driving instrument manageable. The provision of liquids for reaction, washing steps and detection is an issue too. The storage of dissolved enzymes, for instance, will adversely affect the shelf life of the enzymes. Also, storage of dried ingredients next to water or buffer reservoirs may be problematic, because water vapor can penetrate into chambers which contain dried reagents, and thereby affect quality and shelf life of the biochemicals. Accordingly, the liquids should be stored separately in appropriate containers, which can be clicked onto the diagnostic cartridge just in time before use.

In an example of an ELISA analysis chip from our laboratory (Fig. 8.5), pathogenic Francisella tularensis bacteria have been used as test organisms

Page 10: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

8.3 Schematic representation of the operation of the disposable cartridge. Initially, the device is composed of two independent fl uidic systems (a). After collecting the sample, the user connects the collection device to the cassette (b). After insertion in the analyzer, the sample fl ows towards the detection zone (c). (d) The last fl uid to fl ow through the detection zone is an amplifi cation reagent, which creates an optically detectable signal.

Page 11: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Table 8.1 List of companies offering microfl uidic devices for pathogen analysis

Company Analyte* Pathogen Remarks References

NA Pro. Cell

Advanced Liquid Logic

X X X HIV/MRSA In development

Sample prep. via ‘electrowetting’ http://www.liquid- logic.com/technology

Alere X HIV Via CD4 T-cell counting http://www.alere.com/content/dam/alere/docs/pressreleases/1107alere14decpimacd4.pdf

Alere X HIV Via HIV-specifi c antibodies http://www.alere.com/content/dam/alere/docs/pressreleases/1107alere14decpimacd4.pdf

Arcxis X Infectious diseases

DNA and RNA preparation from blood http://www.arcxis.com/

Biosurfi t X Viral infection In development

Compact disc and detection by surface plasmon resonance

http://www.biosurfi t.com/

Cepheid X MRSA/TB Integrated microfl uidic process from sample lysis to data read- out

http://www.cepheid.com/us/cepheid- solutions/systems/genexpert- systems/genexpert- iv/63?view=products

Opko Health Inc. X Infectious diseases

Chip- based ELISA http://www.opko.com/products/point- of-care- diagnostics/hardware- device/

Daktari Diagnostics X HIV CD4+ T-cells are captured, lysed and the impedance of the lysate is monitored

http://www.daktaridx.com/

Focus Dx (Quest) X Dengue viruses and other

Chip- based ELISA http://www.focusdx.com/pdfs/pi/OUS/RT1500GM_G.pdf

Genefl uidics X X Non- specifi ed pathogens

Cartridge for supply of electrochemical ELISA

http://www.genefl uidics.com/index.php

Page 12: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

HandyLab (BD) X Bacteria On-chip sample processing, PCR amplifi cation and detection

http://www.bd.com/geneohm/english/handylab/

Idaho Technologies (BioFire Diagnostics, Inc.)

X Viruses/bacteria In- pouch platform, from sample processing via PCR to fl uorescence detection

http://www.biofi redx.com/

IQuum X Viruses/bacteria Lab- in-a- tube; from sample processing via PCR to fl uorescence detection

http://www.iquum.com/

Micronics (Sony)

X Malaria/ E. coli Immunological test via diffusion within a laminar fl ow of different solutions

http://www.micronics.net/products/research- and-development/active- lab-cards

PositiveID X MRSA, HPV and others

From sample processing to PCR http://positiveidcorp.com/products_dragonfl y.html

Rheonix X Infectious diseases

From sample processing via PCR to fl uorescence detection In development

http://www.rheonix.com/

Wave 80 Biosciences

X X HIV and other viruses

On cartridge amplifi cation of low- concentration analytes

http://www.wave80.com/technology.php

*NA = nucleic acids, Pro. = protein. HIV = human immunodefi ciency virus, HPV = human papilloma virus, MRSA = methicillin- resistant Staphylococcus aureus , TB = (multidrug- resistant) tuberculosis.

Page 13: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

232 Biological Identifi cation

8.4 Operation of the test. (a) The user collects blood from a fi ngerstick with the sample collection device. (b) The user connects the collection device to the disposable cassette; a guiding structure ensures exact alignment of the collection device with the ports in the cassette. (c) After introduction of the cassette in the analyzer, the instrument automatically performs the assay and returns a result to the user on the touchscreen.

(Continued)

Page 14: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 233

and trapped onto the surface of ELISA test chips. The central part of this transparent cyclo- olefi n polymer (COP) chip consists of six detection chambers, where the left four chambers are connected by one channel system. Cyclo- olefi n polymer was chosen as cartridge material despite its comparatively high price because it has excellent optical properties, its material properties facilitate relatively easy structuring of microfl uidic devices by injection moulding, and it can be obtained with a suffi ciently high glass transition temperature.

All three independent sets of detection cavities can be separately addressed by the fl anking turning valves as shown (Becker et al. , 2012). The sample is introduced via a Luer adapter at the upper left side of the chip and the different solution can be applied to the chip by a set of three mini-Luers visible at the right side of the larger Luer adapter.

In addition, there are two upstream cavities in front of the two singular detection zones. These cavities support the long- term storage of dried/lyophilized reagents, which are necessary for the simultaneous performance of reference and control experiments. Finally, the lower left side of the chip shown is occupied by a large waste reservoir with an integrated venting hole covered by a hydrophobic membrane.

8.4 Continued.

Page 15: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

234 Biological Identifi cation

8.5 Schematic illustration of the function of an ELISA test chip (a) and the realization of such a design as a transparent COP chip with a liquid supply management system, turning valves as actuation control, waste reservoir and six detection channels, each of which carries six arrays of spotted target molecules (b).

Page 16: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 235

A corresponding detection test chip (Fig. 8.6–8.8), solely encompassing two detection channels, has been generated by injection moulding of transparent, black., or white COP depending on the requirements of the read- out mode. Figure 8.7 shows fl uorescent (a) and colorimetric (b) monitoring of pathogenic Francisella tularensis bacteria, which have been trapped onto the surface of a chip- based cavity at the indicated position. The colorimetric test was mediated by the reaction of an enzyme (horseradish peroxidise; HRP), giving rise to the violet precipitates shown. The positive control consisted of a trapping molecule, which was directly labelled with the dye or HRP. Irrelevant targets (e.g. Yersinia pestis bacteria) were used as negative controls. As illustrated by Fig. 8.8, fewer than 10 000 bacteria per experiment can unequivocally be identifi ed in this platform.

8.5 Chip- based analysis of nucleic acid- based

analytes in microfl uidic devices

For nucleic acids- based molecular diagnostics, the sample (blood, sputum, saliva, etc.) has usually to be processed in order to extract the nucleic acids. Moreover, the initial concentration of analyte in most analysis scenarios is too low for direct investigation. Accordingly, target sequence multiplications via isothermal amplifi cation, such as nucleic acid sequence- based amplifi cation (NASBA) (Compton, 1991), helicase dependent amplifi cation (HDA) (An et al. , 2005), strand

8.6 Image of a black COP ELISA detection test chip with two detection channels, which carry six arrays of spotted target molecules.

Page 17: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

236 Biological Identifi cation

8.7 Fluorescent (a) and colorimetric (b) monitoring of pathogenic Francisella tularensis bacteria. The colorimetric test was mediated by the reaction of HRP, giving rise to the violet precipitates shown. The positive control consisted of a trapping molecule; irrelevant targets (e.g. Yersinia pestis bacteria) were used as negative controls.

(Continued)

displacement amplifi cation (SDA) (Walker et al. , 1992), rolling circle amplifi cation (RCA) (Lizardi et al. , 1998), or PCR are essential tools that additionally have to be implemented in the cascade of the on- board bioanalytical process chain.

Considering solely the temperature management, isothermal nucleic acid amplifi cation is superior to PCR. Here, however, the utilized enzymes and chemicals

Page 18: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 237

8.7 Continued.

are more sensitive to fl uctuations in different environmental conditions (pH, ionic strength and composition, temperature stability) than the thermophilic polymerase and, in addition, it is a delicate task to coordinate the activity of a whole orchestra of different enzymes, which have to act in concert during isothermal amplifi cation.

PCR is more robust in a biological sense and, refl ecting this robustness, it is possible to amplify target sequences directly out of whole blood (Chas, 2009); the respective inhibitor- resistant amplifi cation is based, however, on the usage of

Page 19: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

238 Biological Identifi cation

specialized enzymes and reaction mixtures, which are exclusively provided by corresponding enzyme manufacturers. Apart from this special situation, PCR still requires at least two, normally three or more, temperature regimes that have to be applied to the chip for more than 20–30 PCR cycles.

If the volume of the PCR mixture is small (nanoliters) and the walls of the reaction cavities are thin, the PCR can be performed stationary in a chamber.

8.8 The graphs display the background- corrected intensity of signals after incubation with the indicated number of F. tularensis bacteria after fl uorescent (a) and colorimetric (b) monitoring.

Page 20: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 239

Here, the increase and, even more important, decrease of the incubation temperature can be performed rapidly enough (<30 min – a period of time that is believed to be acceptable to a user). Alternatively, the fl uid plug (and not the temperature profi le) is mobile and is moved over two or three different temperature zones, which cover all needed incubation temperatures in a constant manner. This so- called ‘continuous- fl ow PCR’ (Kopp et al. , 1996; Köhler et al. , 1998; Gärtner et al. , 2007) is uniquely suited for chip- based nucleic- acid amplifi cation. As a consequence, the fl uid actuation has to be adapted to the required mobility of the plug. Using this approach, very rapid amplifi cations (<10 min for the amplifi cation of single copy genes out of genomic DNA of eukaryotes) can be achieved.

Moreover, techniques for mechanical, ultrasonic, thermal or chemical release of the target sequence have to be realized on board a chip, cartridge or cassette as well. In this line, illustrative examples from our work are given in the following. In most cases, pathogenic organisms can be effi ciently disintegrated (lysed) and, as an additional advantage, the nucleic acid- dissolving buffer can also act as a selective transfer medium for nucleic acids to a functionalized bead surface. Here, the nucleic acid is stored intermediately until all contaminants are washed away. In Fig. 8.9(b), a chip is schematically shown carrying such functionalized beads. Additionally, these beads hold magnetic cores, enabling the controlled actuation of the beads with the help of an external magnet. The magnet, as well as a heating system for incubation at elevated temperatures, is supplied by an instrument (Fig. 8.9(a)), which controls each step of the nucleic acid purifi cation and isolation.

In the next step, the pure nucleic acid has to be amplifi ed (Fig. 8.10 and 8.11). In order to streamline the duration of analysis, a continuous- fl ow PCR with a mobile liquid phase migrating over different stationary temperature phases is favoured (Wang et al. , 2009). One realization of this type of approach is given in Fig. 8.10. Here, the PCR solution is pushed as a slowly but evenly moving plug through a meandering channel with the help of a syringe pump. Thereby, the plug passes two or three (shown in this example) different temperature zones. The geometry of the channel and the number of meanders defi ne the number of PCR cycles and the length of each step within each cycle.

An alternative to the above fl ow- through-PCR is represented by the so- called Boyle-Mariotte-PCR (Fig. 8.11) (Brunklaus et al. , 2012). Here, the PCR solution is pushed against the trapped air in a dead end channel system. The main advantage and disadvantage of this approach in comparison to the fl ow- through-PCR are the reduced space consumption and the higher efforts for fl ow regulation, respectively.

The fi nal step of the process cascade from sample in to analysis result out is the detection of the pathogen- indicating sequence, for which one option is schematically depicted in Fig. 8.12. In this case, the biomolecules, here

Page 21: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

240 Biological Identifi cation

8.9 Image of an instrument controlling the magnetic bead- based purifi cation and isolation of nucleic acid within an appropriate chip (a). Schematic drawing of the design of the chip for magnetic beads- based purifi cation and isolation of nucleic acids (b).

target- specifi c oligonucleotides, are immobilized on the surface of a cavity in an appropriate chip. The immobilized sequence specifi cally catches the matching reverse complementary hybridization partner out of the solution of single- stranded PCR product. Due to the fl uorescent label on one sequence of the PCR primer set, the hybridization complex can be optically identifi ed.

Results of such a hybridization experiment are given in Fig. 8.13. The data indicate that less than 100 pg/ μ l target PCR product can be detected by this approach.

8.6 Future trends

There is no discussion about the urgent need for simple, robust, reliable and rapid POC devices. The intention of this chapter is to give a tour d’horizon about the state of the art of microfl uidic pathogen identifi cation and analysis in quite

Page 22: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 241

8.10 Schematic illustration of the working principle of a so- called fl ow- through-PCR (a). Chip for the performance of a fl ow- through-PCR (b).

Page 23: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

242 Biological Identifi cation

8.11 Schematic illustration of the working principle of a so- called Boyle-Mariotte-PCR (a). Chip for the performance of a Boyle-Mariotte-PCR (b).

Page 24: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 243

different scenarios, such as putative threats from severe contaminations and infections as well as bio- weapons or immediate in situ health care. As also explained, the type of target molecules – DNA, RNA or antigenic protein – strongly infl uences the confi guration of the LoC device. The type of organism – virus, bacteria or eukaryote – also has some effects on the design of the cartridge and the driving instrument. The complexity can additionally be increased, if the

8.12 (a) Schematic drawings of the functionalization process in order to immobilize the trapping biomolecule and (b) the resulting test chip, as already shown in Fig. 8.6.

Page 25: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

244 Biological Identifi cation

number of analytes, reference measurements or points of a standard row, which have to be included in the analysis, is high.

Refl ecting this initial situation, quite different answers have been developed or will be commercialized soon. It is no surprise that currently most LoC devices on the market are directed towards antigenic proteins, which can relatively easily be implemented into a cartridge- based ELISA technology and which can be adapted to the lateral fl ow approach.

8.13 (a) The table displays the relative intensity of the fl uorescence signal after amplifi cation and hybridization of target DNA to immobilized trapping oligonucleotides relative to the amount of applied target DNA. (b) A graphical view of the data in the table.

Page 26: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 245

It is the intention of the more sophisticated LoC devices, however, to exhibit a better performance, a higher sensitivity as well as specifi city, and a higher information density (e.g. inclusion of standard tests or testing of a panel of strains) than the simpler lateral fl ow devices. The technical challenge here, however, is that the ‘comforts’ of the lateral fl ow approach, such as low price per test or the portability of the device, must be retained. Regarding these points, there doubtlessly still remains signifi cant developmental work to do, although technical progress in the area is impressive, as the given examples of commercialized devices illustrate.

We tried to illustrate, by examples of PCR- and fl uorescence detection- based simultaneous investigation of multiple bacterial pathogens, that there is an impressive cohort of problems confronting us as well as currently available solutions to these challenges. PCR requires much space on the cartridge and driving instrument because a precise management of reaction temperature and volume (avoidance of evaporation at elevated temperature) is essential. Apart from this, the special requirements of the bioanalytical protocol and also the need for simultaneous investigation of different test samples imply an ambitious fl ow pattern of different liquids inside the cartridge. Moreover, the provision of these different liquids, as well as the management of actuation, motivates a still- ongoing progression of technical skills.

Currently, the need for smart POC LoCs meets a continuously growing repertoire of microfl uidic tools, which enable scientists and engineers in this fi eld to respond to the above prerequisites in a technically as well as commercially reasonable manner. The near future will certainly see a whole variety of such smart tools and devices.

8.7 Acknowledgements

Part of the work was carried out under the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement 261810.

8.8 References

An , L. , Tang , W. , Ranalli , T. A. , Kim , H. J. , Wytiaz , J. , et al. ( 2005 ), Characterization of a thermostable UvrD helicase and its participation in helicase- dependent amplifi cation , J Biol Chem , 280 , 28952 – 28958 .

Anic , G. M. , and Giuliano , A. R. ( 2011 ), Genital HPV infection and related lesions in men , Prev Med , 53 Suppl 1 , 36 – 41 .

Becker , H. ( 2008 ), Microfl uidics: a technology coming of age , Med Device Technol , 19 , 21 – 24 .

Becker , H. ( 2009 a), Hype, hope and hubris: the quest for the killer application in microfl uidics , Lab Chip , 9 , 2119 – 2122 .

Becker , H. ( 2009 b), It’s the economy . . . , Lab Chip , 9 , 2759 – 2762 . Becker , H. , Klemm , R. , Sewart , R. and Gärtner , C. ( 2012 ), A multiport metering valve

technology for on- chip valveing , Proc. MicroTAS 2012, Okinawa , 308 – 310 .

Page 27: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

246 Biological Identifi cation

Blazkova , M. , Koets , M. , Rauch , P. and Amerongen , A. V. ( 2009 ), Development of a nucleic acid lateral fl ow immunoassay for simultaneous detection of Listeria spp. and Listeria monocytogenes in food , Eur Food Res Technol , 229 , 867 – 874 .

Blow , N. ( 2009 ), Microfl uidics: the great divide , Nature Meth 6 , 683 – 686 . Briggs , C. , Kimber , S. and Green L. ( 2012 ), Where are we at with point- of-care testing in

haematology? Br J Haematol , 158 , 679 – 690 . Brunklaus , S. , Hansen-Hagge , T. E. , Erwes , J. , Höth , J. , Jung , M. , et al. ( 2012 ), Fast nucleic

acid amplifi cation for integration in point- of-care applications , Electrophoresis , 33 , 3222 – 3228 .

Chard , T. ( 1992 ), Pregnancy tests: a review , Hum Reprod , 7 , 701 – 710 . Chas , A. ( 2009 ), New Developments in PCR , BioTechniques Special Issue , 46 ,

375 – 376 . Chin , C. D. , Laksanasopin , T. , Cheung , Y. K. , Steinmiller , D. , Linder , V. , et al. ( 2011 ),

Microfl uidics- based diagnostics of infectious diseases in the developing world , Nat Med , 17 , 1015 – 1019 .

Chin , C. D. , Linder , V. and Sia , S. K. ( 2012 ), Commercialization of microfl uidic point- of-care diagnostic devices , Lab Chip , 12 , 2118 – 2134 .

Clerc , O. and Greub , G. ( 2010 ), Routine use of point- of-care tests: usefulness and application in clinical microbiology , Clin Microbiol Infect , 16 , 1054 – 1061 .

Compton , J. ( 1991 ), Nucleic acid sequence- based amplifi cation , Nature , 350 , 91 – 92 . Dutse , S. W. and Yusof , N. A. ( 2011 ), Microfl uidics- based lab- on- chip systems in DNA-

based biosensing: an overview , Sensors (Basel) , 11 , 5754 – 5768 . Engvall , E. and Perlmann , P. ( 1971 ), Enzyme- linked immunosorbent assay (ELISA).

Quantitative assay of immunoglobulin G , Immunochemistry , 8 , 871 – 874 . Focke , M. , Stumpf , F. , Roth , G. , Zengerle , R. and von Stetten , F. ( 2010 ), Centrifugal

microfl uidic system for primary amplifi cation and secondary real- time PCR , Lab Chip , 10 , 3210 – 3212 .

Franz , D. R , Jahrling , P. B. , Friedlander , A. M. , McClain , D. J. , et al. ( 1997 ), Clinical recognition and management of patients exposed to biological warfare agents , JAMA , 278 , 399 – 411 .

Gärtner , C. , Klemm , R. and Becker , H. ( 2007 ), Methods and instruments for continuous- fl ow PCR on a chip . In: Proceedings of SPIE microfl uidics, BioMEMS and medical microsystems V , San Jose, 6465 , 6465502 – 1 – 6465502 – 8 .

Glad , C. and Grubb , A. O. ( 1978 ), Immunocapillary migration—a new method for immunochemical quantitation , Anal Biochem , 85 , 180 – 187 .

Gordon , C. A. , Gray , D. J. , Gobert , G. N. and McManus , D. P. ( 2011 ), DNA amplifi cation approaches for the diagnosis of key parasitic helminth infections of humans , Mol Cell Probes , 25 , 143 – 152 .

Haeberle , S. and Zengerle , R. ( 2007 ), Microfl uidic platforms for lab- on-a- chip applications , Lab Chip , 7 , 1094 – 1110 .

Henares , T. G. , Mizutani , F. and Hisamoto , H. ( 2008 ), Current development in microfl uidic immunosensing chip , Anal Chim Acta , 611 , 17 – 30 .

Ibrahim , A. , Darwish , I. A. , Al-Obaid , A. R. M. and Al-Malaq , H. A. ( 2009 ), New highly sensitive enzyme immunoassay for the determination of pravastatin in human plasma , Talanta , 79 , 1478 – 1483 .

Janasek , D. , Franzke , J. and Manz , A. ( 2006 ), Scaling and the design of miniaturized chemical- analysis systems , Nature , 442 , 374 – 380 .

Page 28: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 247

Kim , J. , Johnson , M. , Hill , P. and Gale , B. K. ( 2009 ), Microfl uidic sample preparation: cell lysis and nucleic acid purifi cation , Integr Biol , 1 , 574 – 586 .

Köhler , J. M. , Dillner , U. , Mokansky , A. , Poser , S. and Schulz , T. ( 1998 ), Micro Channel Reactors for Fast Thermocycling , 2nd International Conference on Microreaction Technology , New Orleans , LA, 241 – 247 .

Kopp , M. U. , De Mello , A. J. and Manz , A. ( 1998 ), Chemical Amplifi cation: Continuous-Flow PCR on a Chip , Science , 280 , 1046 – 1048 .

Kuswandi , B. , Nuriman , Huskens, J. and Verboom , W. ( 2007 ), Optical sensing systems for microfl uidic devices: A review , Anal Chim Acta , 601 , 141 – 155 .

Lee , B. S. , Lee , J. N. , Park , J. M. , Lee , J. G. , Kim , S. , et al. ( 2009 ), A fully automated immunoassay from whole blood on a disc , Lab Chip , 9 , 1548 – 1555 .

Lee , S. J. and Lee , S. Y. ( 2004 ), Micro total analysis system (micro-TAS) in biotechnology , Appl Microbiol Biotechnol , 64 , 288 – 299 .

Lee , W. G. , Kim , Y. G. , Chung , B. G. , Demirci , U. and Khademhosseini , A. ( 2010 ), Nano/Microfl uidics for diagnosis of infectious diseases in developing countries , Adv Drug Deliv Rev , 62 , 449 – 457 .

Lewandrowski , K. ( 2009 ), Point- of-care testing: an overview and a look to the future (circa 2009, United States) , Clin Lab Med , 29 , 421 – 432 .

Litman , D. J. , Lee , R. H. , Jeong , H. J. , Tom , H. K. , Stiso , S. N. , et al. ( 1983 ), An internally referenced test strip immunoassay for morphine , Clin Chem , 29 , 1598 – 1603 .

Lizardi , P. M. , Huang , X. , Zhu , Z. , Bray-Ward , P. , Thomas , D. C. , et al. ( 1998 ), Mutation detection and single- molecule counting using isothermal rolling- circle amplifi cation , Nat Genet , 19 , 225 – 232 .

Loubiere , S. and Moatti , J. P. ( 2010 ), Economic evaluation of point- of-care diagnostic technologies for infectious diseases , Clin Microbiol Infect , 16 , 1070 – 1076 .

Lu , X. , Samuelson , D. R. , Xu , Y. , Zhang , H. , Wang , S. , et al. ( 2013 ), Detecting and tracking nosocomial methicillin- resistant Staphylococcus aureus using a microfl uidic SERS biosensor , Anal Chem , 85 , 2320 – 2327 .

Mak , P. W. , Jayawardena , S. and Poon L. L. ( 2012 ), The evolving threat of infl uenza viruses of animal origin and the challenges in developing appropriate diagnostics , Clin Chem , 58 , 1527 – 1533 .

Manz , A. , Graber , N. and Widmer , H. M. ( 1990 ), Miniaturized total chemical analysis systems: a novel concept for chemical sensing, Sens Actuators B , 1 , 244 – 248 .

Mark , D. , Haeberle , S. , Roth , G. , von Stetten , F. and Zengerle , R. ( 2010 ), Microfl uidic lab- on-a- chip platforms: requirements, characteristics and applications , Chem Soc Rev , 39 , 1153 – 1182 .

Mark , D. , von Stetten , F. and Zengerle , R. ( 2012 ), Microfl uidic Apps for off- the-shelf instruments , Lab Chip , 12 , 2464 – 2468 .

Martinez , A. W. ( 2011 ), Microfl uidic paper- based analytical devices: from POCKET to paper- based ELISA , Bioanalysis , 3 , 2589 – 2592 .

McCalla , S. E. and Tripathi , A. ( 2011 ), Microfl uidic reactors for diagnostics applications , Annu Rev Biomed Eng , 13 , 321 – 343 .

Minkstimiene , A. K. , Ramanaviciene , A. and Ramanavicius , A. ( 2009 ), Surface plasmon resonance biosensor for direct detection of antibodies against human growth hormone , Analyst , 134 , 2051 – 2057 .

Mocharla , H. , Mocharla , R. and Hodes , M. E. ( 1990 ), Coupled reverse transcription- polymerase chain reaction (RT-PCR) as a sensitive and rapid method for isozyme genotyping , Gene , 93 , 271 – 275 .

Page 29: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

248 Biological Identifi cation

Mothershed , E. A. and Whitney , A. M. ( 2006 ), Nucleic acid- based methods for the detection of bacterial pathogens: present and future considerations for the clinical laboratory , Clin Chim Acta , 363 , 206 – 220 .

Mullis , K. , Faloona , F. , Scharf , S. , Saiki , R. , Horn , G. , et al. ( 1986 ), Specifi c enzymatic amplifi cation of DNA in vitro: the polymerase chain reaction , Cold Spring Harb Symp , 51 , 263 – 273 .

Nguyen , N. T. and Wu , Z. G. ( 2005 ), Micromixers—a review , J Micromech Microeng , 15 , R1 – R16 .

Niemz , A. and Boyle , D. S. ( 2012 ), Nucleic acid testing for tuberculosis at the point- of-care in high- burden countries , Expert Rev Mol Diagn , 12 , 687 – 701 .

Oh , K. W. and Ahn , C. H. ( 2006 ), A review of microvalves , J Micromech Microeng , 16 , R13 – R39 .

Pacifi ci , R. , Farré , M. , Pichini , S. , Ortuño , J. , Roset , P. N. , et al. ( 2001 ), Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers , J Anal Toxicol , 25 , 144 – 146 .

Park , S. , Zhang , Y. , Lin , S. , Wang , T. H. and Yang , S. ( 2011 ), Advances in microfl uidic PCR for point- of-care infectious disease diagnostics , Biotechnol Adv , 29 , 830 – 839 .

Rica , R. D. L. , Baldi , A. , Sanchez , C. F. and Matsui , H. ( 2009 ), Single- cell pathogen detection with a reverse- phase immunoassay on impedimetric transducers , Anal Chem , 81 , 7732 – 7736 .

Rossier , J. S. and Girault , H. H. ( 2001 ), Enzyme linked immunosorbent assay on a microchip with electrochemical detection , Lab Chip , 1 , 153 – 157 .

Saiki , R. K. , Gelfand , D. H. , Stoffel , S. , Scharf , S. J. , Higuchi , R. , et al. ( 1988 ), Primer- directed enzymatic amplifi cation of DNA with a thermostable DNA , Science , 239 , 487 – 491 .

Saxena , U. , Sauvaget , C. and Sankaranarayanan , R. ( 2012 ), Evidence- based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India , Asian Pac J Cancer Prev , 13 , 1699 – 1703 .

Schulte , T. , Bardell , R. and Weigl , B. H. ( 2000 ), Sample acquisition and control on-chip microfl uidic sample preparation , JALA , 5 , 83 – 86 .

Shyu , R. H. , Shyu , H. F. , Liu , H. W. and Tang , S. S. ( 2002 ), Colloidal gold- based immunochromatographic assay for detection of ricin , Toxicon , 40 , 255 – 258 .

Siebenhaar , R. , Mushholt , P. B. , Forst , T. , Weber , M. M. , Maurer , R. , et al. ( 2010 ), Laboratory evaluation of a new lateral- fl ow-based point- of-care rapid test for assessment of chronic systemic infl ammation , J Diabetes Sci Technol , 4 , 717 – 722 .

Van Weemen , B. K. and Schuurs , A. H. ( 1971 ), Immunoassay using antigen- enzyme conjugates, FEBS Lett , 15 , 232 – 236 .

Vilkner , T. , Janasek , D. and Manz , A. ( 2004 ), Micro total analysis systems. Recent developments , Anal Chem , 76 , 3373 – 3386 .

von Lode , P. ( 2005 ), Point- of-care immunotesting: approaching the analytical performance of central laboratory methods , Clin Biochem , 38 , 591 – 606 .

Walker , G. T. , Fraiser , M. S. , Schram , J. L. , Little , M. C. , Nadeau , J. G. , and et al. ( 1992 ), Strand displacement amplifi cation – an isothermal, in vitro DNA amplifi cation technique , Nucleic Acids Res , 20 , 1691 – 1696 .

Wang , J. H. , Chien , L. J. , Hsieh , T. M. , Luo , C. H. , Chou , W. P. , et al. ( 2009 ), A miniaturized quantitative polymerase chain reaction system for DNA amplifi cation and detection , Sensor Actuat B-Chem , 141 , 329 – 337 .

Page 30: Biological Identification || Microfluidic devices for rapid identification and characterization of pathogens

Microfl uidic devices for rapid identifi cation of pathogens 249

Weile , J. and Knabbe , C. ( 2009 ), Current applications and future trends of molecular diagnostics in clinical bacteriology , Anal Bioanal Chem , 394 , 731 – 742 .

Zhang , C. and Xing , D. ( 2007 ), Miniaturized PCR chips for nucleic acid amplifi cation and analysis: latest advances and future trends , Nucl Acids Res , 35 , 4223 – 4237 .